Status:
COMPLETED
Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium
Lead Sponsor:
A.O.U. Città della Salute e della Scienza
Conditions:
Hypopituitarism
Eligibility:
All Genders
20-50 years
Phase:
PHASE4
Brief Summary
The effects of acute administration of non-steroidal anti-inflammatory drugs (NSAIDs) on the neuroendocrine regulation of hydro-electrolytic metabolism are not precisely known to date. Although the m...
Eligibility Criteria
Inclusion
- \- Any adult healthy subject (with age 20-50 years old) not meeting any of the exclusion criteria listed below
Exclusion
- BMI \< 18.5 kg/m2 or \> 25 kg/m2
- Any active pharmacological treatment
- Pregnancy or breastfeeding
- History of polyuria/polydipsia syndrome
- History of dysionia
- History of peptic disease
- History of gastrointestinal bleeding
- History of kidney disease
- History of heart disease
- History of asthma
- Known allergy to NSAIDs
- Any current acute medical condition
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT05188131
Start Date
October 1 2021
End Date
December 31 2021
Last Update
January 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AOU Città della Salute e della Scienza
Turin, Piedmont, Italy, 10126